Overall Technical outlook

Price Summary

Sun Pharmaceutical Industries Limited's stock, on 2025-10-17 opened at 1658.2, climbed to a high of 1692.0, dropped to a low of 1656.7, and closed up 1.26% at 1679.1, with 1594068 shares traded.
Over the past 52 weeks, the stock reached a maximum price of 1910.35 and a minimum price of 1563.3.
37 analysts suggest that SUNPHARMA's future price will lie between 1525.0 and 2450.0, with an average expected price of roughly 1941.4054.

Technicals

Support and Resistance: The current price for SUNPHARMA is 1679.1, supported at 1647.6 with resistance at 1686.2. This indicates a trading range where 1647.6 might prevent further declines, while 1686.2 could hinder additional gains.
SUNPHARMA supportResistance 2359ed
Support/Resistance for SUNPHARMA


Aroon: The bullish trend indicated by Aroon persists, with Aroon Up holding at the 100 level for SUNPHARMA. This shows strong upward momentum, but further analysis using additional indicators is necessary to determine the trend's sustainability and future potential.
SUNPHARMA aroon 2359ed
Aroon chart for Sun Pharmaceutical Industries Limited


Bol. Bands: The current state of the BOLL BANDS is neutral, providing no clear signals for either an upward or downward movement. This indicates that the market may be in a state of equilibrium, with no strong momentum in either direction.
SUNPHARMA bbands 2359ed
Bolinger Bands chart for Sun Pharmaceutical Industries Limited


Parabolic SAR: The PSAR maintains a bullish outlook, reinforcing a support level that could help uphold the market's upward trend. This suggests that the market is likely to continue climbing, with the support providing a solid base for further gains.
SUNPHARMA psar 2359ed
Parabolic Stop and Reverse chart for Sun Pharmaceutical Industries Limited


Stochastic: The K-line has dipped below the D-line on the stochastic indicator while staying above 80, indicating that a bearish price move may be imminent. This pattern suggests that the market's upward momentum is faltering for Sun Pharmaceutical Industries Limited, which could result in a reversal. Investors should pay attention to this potential change in trend.
SUNPHARMA stoch 2359ed
Stochastic chart for Sun Pharmaceutical Industries Limited


Tripple Moving Agerage: The Tripple MOVING AVG is neutral, showing no definitive signals of a trend either upward or downward. This neutral stance indicates a period of market indecision, where the direction is unclear.
SUNPHARMA trippleSMA 2359ed
Tripple SMA chart for Sun Pharmaceutical Industries Limited


When analyzing a company, its fundamentals—such as earnings, management efficiency, and strategic initiatives—must be considered alongside technical data. The context of the industry in which the company operates also plays a key role, as market trends and competitive dynamics can significantly impact performance. By taking a comprehensive approach, combining both fundamental and technical analysis, one can gain a deeper understanding of the company's potential for growth or risk.